CSTL
Castle Biosciences Inc
35.20$
+0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +270.8% | -136.8% | – | -2.8% | +4.4% | -124.8% | – | +8.7% | +19.0% | -182.2% | – | – | |
| – | +1.6% | +3.6% | +0.2% | +5.8% | +62.9% | +416.0% | -88.5% | +11.8% | -1.0% | +4.0% | +3.6% | – | |
| – | -9.5% | +7.4% | +4.0% | -1.2% | -12.2% | -2.3% | +0.3% | +8.0% | -5.7% | -14.3% | +18.5% | – | |
| – | – | -345.2% | – | -59.4% | +155.5% | -1,127.8% | – | +35.2% | +21.4% | -238.6% | – | – | |
| – | +54.5% | +141.3% | -42.9% | +22.0% | +18.6% | -37.4% | +95.4% | +60.1% | -51.6% | +73.4% | -30.5% | – | |
| – | -21.0% | +156.8% | +8.7% | -30.9% | – | -488.8% | +26.5% | -35.2% | – | -392.2% | -38.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,381.5% | -88.2% | +29.7% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +8.3% | +0.0% | – | -119.5% | -12.9% | -11.1% | +0.0% | – | |
| – | -7,426.7% | – | -99.6% | +1,895.2% | -742.6% | -71.2% | – | -1,009.9% | +399.3% | +9.7% | -82.4% | – | |
| – | – | -308.6% | – | +257.9% | +163.7% | -221.3% | – | – | +838.1% | -269.9% | – | – | |
| – | +478.6% | -208.1% | – | -9.6% | -1.0% | -164.2% | – | -32.5% | +153.3% | -275.1% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.